Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M FitzGerald

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|February 5, 1989
Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1B M McKeever, M A Navia, P M Fitzgerald, et al.
Nature|February 16, 1989
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1M A Navia, P M Fitzgerald, B M McKeever, et al.
The Journal of Biological Chemistry|June 8, 2001
Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamaseJ H Toney, G G Hammond, P M Fitzgerald, et al.
Protein Science : a Publication of the Protein Society|October 1, 1995
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzymeJ W Becker, A I Marcy, L L Rokosz, et al.
Journal of Medicinal Chemistry|May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.
Journal of Medicinal Chemistry|January 20, 1995
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active siteM K Holloway, J M Wai, T A Halgren, et al.
Chemistry & Biology|May 23, 1998
Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamaseJ H Toney, P M Fitzgerald, N Grover-Sharma, et al.
Journal of Medicinal Chemistry|August 16, 1996
Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluationA K Ghosh, J F Kincaid, D E Walters, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|February 5, 1989
Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1B M McKeever, M A Navia, P M Fitzgerald, et al.
Nature|February 16, 1989
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1M A Navia, P M Fitzgerald, B M McKeever, et al.
The Journal of Biological Chemistry|June 8, 2001
Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamaseJ H Toney, G G Hammond, P M Fitzgerald, et al.
Protein Science : a Publication of the Protein Society|October 1, 1995
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzymeJ W Becker, A I Marcy, L L Rokosz, et al.
Journal of Medicinal Chemistry|May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.
Journal of Medicinal Chemistry|January 20, 1995
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active siteM K Holloway, J M Wai, T A Halgren, et al.
Chemistry & Biology|May 23, 1998
Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamaseJ H Toney, P M Fitzgerald, N Grover-Sharma, et al.
Journal of Medicinal Chemistry|August 16, 1996
Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluationA K Ghosh, J F Kincaid, D E Walters, et al.
Pageof 3